179 related articles for article (PubMed ID: 27074575)
1. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
[TBL] [Abstract][Full Text] [Related]
2. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
[TBL] [Abstract][Full Text] [Related]
4. Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.
Doucette T; Latha K; Yang Y; Fuller GN; Rao A; Rao G
Neuro Oncol; 2014 Sep; 16(9):1220-8. PubMed ID: 24676140
[TBL] [Abstract][Full Text] [Related]
5. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
[TBL] [Abstract][Full Text] [Related]
7. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
[TBL] [Abstract][Full Text] [Related]
8. In vitro neurosphere formation correlates with poor survival in glioma.
C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
[TBL] [Abstract][Full Text] [Related]
9. Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.
Sato A; Mizobuchi Y; Nakajima K; Shono K; Fujihara T; Kageji T; Kitazato K; Matsuzaki K; Mure H; Kuwayama K; Sumi A; Saya H; Sampetrean O; Nagahirao S
J Neurooncol; 2017 Apr; 132(2):231-238. PubMed ID: 28283800
[TBL] [Abstract][Full Text] [Related]
10. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.
Broniscer A; Baker SJ; West AN; Fraser MM; Proko E; Kocak M; Dalton J; Zambetti GP; Ellison DW; Kun LE; Gajjar A; Gilbertson RJ; Fuller CE
J Clin Oncol; 2007 Feb; 25(6):682-9. PubMed ID: 17308273
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
14. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis.
Xu T; Zhou Q; Zhou J; Huang Y; Yan Y; Li W; Wang C; Hu G; Lu Y; Chen J
Cancer Sci; 2011 May; 102(5):959-66. PubMed ID: 21272160
[TBL] [Abstract][Full Text] [Related]
15. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
Thorarinsdottir HK; Santi M; McCarter R; Rushing EJ; Cornelison R; Jales A; MacDonald TJ
Clin Cancer Res; 2008 Jun; 14(11):3386-94. PubMed ID: 18519768
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance analysis of malignant transformation in recurrent glioma.
Jalbert LE; Neill E; Phillips JJ; Lupo JM; Olson MP; Molinaro AM; Berger MS; Chang SM; Nelson SJ
Neuro Oncol; 2016 Aug; 18(8):1169-79. PubMed ID: 26911151
[TBL] [Abstract][Full Text] [Related]
18. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
20. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
Dai B; Pieper RO; Li D; Wei P; Liu M; Woo SY; Aldape KD; Sawaya R; Xie K; Huang S
Cancer Res; 2010 Apr; 70(7):2951-61. PubMed ID: 20332230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
